Automated Blood Processing Equipment Market (2025 - 2035)

Automated Blood Processing Equipment Market Outlook 2025 to 2035

Automated blood processing equipment market will shine in the decade to come, as blood-processing technologies are improving along with the demand for good and accurate automated solutions for all kinds of blood testing involved with transfusions or donation centers.

The market will see an estimated value of USD 50.1 billion in 2025, while the market is forecasted to be worth USD 108.2 billion by 2035, with an approximate CAGR of 8% over the period under consideration.

They increase the quality of blood components, minimize human errors, and enhance the overall efficiency of the blood processing operation. Apprehensive manufacturing standards enhancing safety have spurred the acceptance of automation into the healthcare arena and activated blood donation demand, facilitating entry of the stakeholders into this market.

Market Metrics

Metric	Value
Market Size (2025E)	USD 50.1 Billion
Market Value (2035F)	USD 108.2 Billion
CAGR (2025 to 2035)	8%

Regional Market Trends

North America

The automated blood processing equipment marketis expected to continue its dominance in North America by creating favorable conditions for the rise of this current market by being highly integrating the health establishment and the huge investment in medical technology.

In particular, the large number of advanced medical equipment demands from the USA hospitals, blood banks, and transfusion centers would have the momentum added to this market growth. Awareness of blood safety and efficiency is increasing and will continue, together with supportive health policies, to provide market growth. Further, increasing surgery and emergency treatments will require blood processing systems, sustaining the growth of the market in North America.

Europe

Europe has a significant portion of the market for automated blood processing equipment, with German, French, and British investments into health automation intended to improve blood donation and processing. The International issue of blood safety and quality regulators in the Union will additionally support the entry of automated blood processing systems. In addition, the aging population and increasing demand for blood transfusions in the medical field will foreseeably galvanize a further rise in the coming years.

Asia-Pacific

The market for automated blood processing systems in the Asia-Pacific region is expected to grow fastest since rapid health advances, increasing healthcare investments, as well as the growing need for blood donation.

Improvement in healthcare infrastructure and automation technologies in countries like China and India has also enabled the uptake of automated blood processing systems. The improving healthcare systems around the region are anticipated to offer a significant opportunity for market growths, especially in developing countries where the need for blood transfusion services is increasing.

Challenges and Opportunities

Challenges

High Cost of Implementation

The poor cost of acquisition of the automated blood processing equipment can discourage the health care providers, particularly in developing regions with limited financial resources. Again, specialized training of health professionals to enable them to run these automated systems would add to the operational cost.

Opportunities

Technological Advancements and Increasing Demand for Safe Blood Processing

Huge potential opportunities exist through technological advancements in automated blood processing systems, including blood separation techniques, storage methods, and testing technology. The other well-thought-out anticipated cause of growth in this market includes the increasing need for safe, effective, and high-quality blood components, especially in specialized care and trauma centers.

The increase within consumers concerning awareness of blood safety as well as government programs to improve and make blood transfusion safer and better is expected to drive the market for automated solutions in healthcare settings.

Shifts in the Automated Blood Processing Equipment Market from 2020 to 2024 and Future Trends 2025 to 2035

From the technological advancements occurring, demand for blood transfusions, and improvements in hospital efficiency, the automated blood processing equipment marketis expected to achieve explosive growth from the year 2025 to 2035.

The growth of this market is primarily driven by increasing automation of blood processing activities for improved accuracy and reduced human error and turnaround time. Technological advancements in automation, AI, and data analytics are somehow bridging the performance and capabilities of blood processing equipment further.

Market Shifts: 2020 to 2024 vs. 2025 to 2035

Key Dimensions	2020 to 2024
Growth Drivers	Need for improved accuracy in blood processing, growing demand for blood transfusions, technological advancements
Technology Trends	Fully automated blood processing, AI-powered blood processing systems, integrated blood testing
Applications	Blood collection, separation, storage, and preparation of blood products
End-User Adoption	Blood banks, hospitals, clinics, healthcare centers
Geographic Demand	North America, Europe, Asia-Pacific
Regulatory Landscape	FDA, CE marking for blood processing devices, blood safety regulations
Innovation Focus	Automation of blood separation, monitoring of blood quality
Supply Chain Dynamics	Established relationships with hospitals and blood banks

Key Dimensions	2025 to 2035
Growth Drivers	Increasing healthcare infrastructure, automation, regulatory compliance, and rising surgeries requiring blood products
Technology Trends	Real-time processing systems, advanced automation, AI-enhanced data analytics, next-gen blood collection equipment
Applications	Blood component separation, plateletpheresis , plasma collection, and therapeutic apheresis
End-User Adoption	Blood banks, hospitals, research organizations, and advanced healthcare facilities
Geographic Demand	North America, Europe, Asia-Pacific, Latin America, Middle East
Regulatory Landscape	More stringent regulations for blood safety and traceability of blood products, global standards for automation
Innovation Focus	Smart blood processing solutions, AI-based analytics, integration with other medical equipment for real-time monitoring
Supply Chain Dynamics	Expanded global supply chains, partnerships with blood collection centers, and tech companies for AI integration

Country-wise Insights

United States

Most of the momentum in the presently growing automated blood processing equipment marketin the United States can be attributed to the increasing demand to confer in healthcare institutions the efficient, precise, and safe approach in blood processing.

Such systems are required due to developments in the technology of health care, an aging population, and increased number of surgeries and medical procedures that demand some form of blood transfusion. Furthermore, it is home to some of the leading manufacturers and research laboratories that actively invent various automated systems for better blood collection, processing, and storage.

Country	CAGR (2025 to 2035)
United States	8.0%

United Kingdom

The automated blood processing equipment marketis showing consistent growth in the United Kingdom because of NHS efforts to increase the efficiency and quality of healthcare provision for patients. The rise of automation in the health facilities is contributing to the market by its increasing adoption in blood testing, transfusion, and diagnostics. Given that the existing population is aging and with increasing surgical procedures, the demand for automated blood processing systems can only increase.

Country	CAGR (2025 to 2035)
United Kingdom	7.5%

European Union

With Germany, France, and Italy contributing a significant amount to the automated blood processing equipment marketin the European Union, it is in an expanding phase. Increased investments in automating technologies come because the EU is more focused on improving healthcare systems and ensuring blood safety. Since hospitals and blood banks in the region are automating their processes to reduce human error and enhance efficiency, the market is quite promising for gradual growth.

Country	CAGR (2025 to 2035)
European Union	8.2%

Japan

Technological advancements in medicine and necessary improvements in blood collection and transfusion processes are gaining popularity in Japan's automated blood processing equipment market. With the elderly population demanding greater surgical and medical procedures, higher demand for such automation is required. Ongoing development is taking place in Japan to further improve the safety and efficiency of blood processing systems.

Country	CAGR (2025 to 2035)
Japan	8.1%

South Korea

Alongside investments for health-care infrastructure, an aging population, and developments in blood processing technologies, these are some drivers of growth in South Korea's automated blood processing equipment market. The focus of that country is on enhancing medical services and cutting down costs of health care through injection of automation systems in hospitals and blood banks, thus boosting the growth of the market.

Country	CAGR (2025 to 2035)
South Korea	8.3%

Automated Blood Processing Equipment-Segmentation Outlook

Advancing Precision in Blood Component Separation and Processing

Between 2025 and 2035, the automated blood processing equipment marketis expected to experience rapid growth mainly because of the increasing demand for highly precise blood separation and processing, advances in automation technology, and the growing demand for effective blood management systems.

These automated systems further optimize the safety and quality of blood products- the processing for transfusion or medical treatment is as effective. Automation eliminates most of the possible human error, maximizes efficiency, and serves the increased demand for blood products in hospitals, blood banks, and pathology labs.

Market Share by Product Type

Automatic Blood Separator to Lead the Market

Product Type	Market Share
Automatic Blood Separator	54.7%

The Automatic Blood Separator segment is poised to become the leader in 2025 with a 54.7% market share. Automatic blood separators are capable of effectively removing blood components like plasma, red blood cells, and platelets from the whole blood. Besides ensuring the quality and safety of blood products with the automation of the separation process to reduce the risk of contamination, these devices also increase the yield of vital components for therapeutic use.

The demand for automatic blood separators keeps growing due to blood component therapy requiring transfusions, chronic diseases on the rise, and growing acceptance of automated devices for rapid and safe blood processing.

Market Share by End-Use

Hospitals to Hold the Largest Share

End-Use	Market Share
Hospitals	45.2%

The Hospitals segment accounted for the largest slice of the entire market share, representing 45.2% of the total market in 2025. Automated blood processing equipment is generally used in the hospital setting due to both the increase in the number of patients needing blood transfusions and its common use in trauma care, surgeries, and cancer treatments. In hospitals, automated systems contribute to improved efficient management of blood resources and hence support the rising demand for medical treatments requiring high-quality blood component.

Automated blood processing systems demand in hospitals is favored by rising surgical procedures, trauma care cases, and cancer treatments requiring blood transfusions in addition to the technology improvements. Supporting patient safety and decreasing irrelevant transfusion risks also encourage the increased acceptance of automated blood processing systems in hospitals.

Competitive Outlook

The rapid growth anticipated for automated blood processing equipment should arise between 2025 and 2035, as increasing needs prevail for functioning blood processing systems in clinical and hospital settings. Such systems minimize manual efforts, boost accuracy, and simplify blood testing and transfusion operations.

Additionally, factors such as rising incidences of blood-related disorders, increasing demand for blood donations, and ever-rising acceptance of the automation process in health care have all credited their growth to the present market scenario.

Market Share Analysis by Company

Company Name	Estimated Market Share (%)
Terumo Corporation	20-25%
Haemonetics Corporation	15-20%
Fresenius Kabi	12-15%
Abbott Laboratories	10-15%
Bio-Rad Laboratories	8-10%
Other Companies (combined)	30-35%

Key Company Offerings and Activities

Company Name	Key Offerings/Activities
Terumo Corporation	In 2024, Terumo introduced an advanced blood separation system that integrates real-time monitoring for quality control. The company plans to enhance its product lineup in 2025 with new automation features to streamline blood donation and transfusion processes.
Haemonetics Corporation	Haemonetics launched a fully automated blood processing unit in 2024, aimed at improving blood collection and storage efficiency. The company plans to expand its offerings in 2025 by incorporating AI-driven systems for more precise and faster processing.
Fresenius Kabi	Fresenius Kabi enhanced its blood processing equipment portfolio in 2024 with the introduction of a compact, user-friendly system for blood transfusion management. The company is set to integrate digital tracking and monitoring features in 2025 to improve operational efficiency.
Abbott Laboratories	Abbott launched an innovative automated blood typing system in 2024, enabling quicker and more accurate matching of blood donors and recipients. The company is expected to introduce further automation capabilities in 2025 to enhance the functionality of its blood processing equipment.
Bio-Rad Laboratories	Bio-Rad introduced an automated blood screening system in 2024 for faster detection of blood-borne pathogens. In 2025, Bio-Rad plans to incorporate next- gen sequencing technologies into its blood processing systems for enhanced diagnostic accuracy.

Key Company Insights

Terumo Corporation (20-25%)

Terumo remains a leader in the automated blood processing equipment market, thanks to its continuous innovations and reliable, high-quality products. The company’s advanced blood separation and donation systems are widely used across healthcare facilities, and its focus on real-time quality monitoring and automation ensures high efficiency and precision. Terumo's robust portfolio positions it well for market growth, particularly in developed and emerging markets.

Haemonetics Corporation (15-20%)

Haemonetics is recognized for its comprehensive blood management solutions, particularly in the field of blood processing. Its automated blood processing units have garnered popularity in blood centers and hospitals for their efficiency and accuracy. The company’s future plans to integrate AI and machine learning into its systems will further enhance its competitive positioning.

Fresenius Kabi (12-15%)

Fresenius Kabi’s expertise in healthcare and blood processing technologies has allowed the company to remain a strong player in the market. With its compact, cost-effective systems, Fresenius Kabi has gained significant traction in smaller healthcare facilities and regional blood banks. The company’s focus on integrating automation and digital monitoring solutions will contribute to its sustained growth.

Abbott Laboratories (10-15%)

Abbott Laboratories continues to strengthen its position in the automated blood processing market with its innovative blood typing and blood screening systems. Abbott’s focus on developing automated solutions for rapid and accurate blood matching ensures its relevance in the healthcare sector, especially in blood transfusion centers and clinics.

Bio-Rad Laboratories (8-10%)

Bio-Rad Laboratories' automated blood screening systems are pivotal for detecting blood-borne pathogens and ensuring blood safety. The company is at the forefront of integrating molecular diagnostic technologies into its equipment, which enhances its ability to offer more precise and reliable blood testing solutions. Bio-Rad’s future focus on next-gen sequencing for blood processing will help it maintain a competitive edge.

Other Key Players (30-35% Combined)

• Baxter International
• Grifols S.A.
• Medtronic PLC
• GE Healthcare
• Cobe Cardiovascular, Inc.
• Lifeblood
• Wako Pure Chemical Industries, Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co.
• Mediware Information Systems, Inc.
• Sichuan Kelun Pharmaceutical Co. Ltd.

Key Segmentation

By Product Type:

• Automatic Blood Separator
• Automatic Blood Processing System

By End-User:

• Hospitals
• Blood Banks
• Pathology Laboratories
• Ambulatory Surgical Centres

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)